Research Directory

A new paradigm for antibiotic drug development

Read more

The search continues for new antibiotics

Read more

Why epigenetics is important to Pharma

Read more

Analysis of Special Protocol Assessments for oncology

Read more

A good beginning in the perilous biotech business

Read more

Transgene in vanguard of oncolytic virus therapy

Read more

A new business model for Pharma

Read more

US Special Protocol Assessments for Oncology

Read more

European biotechs start to look undervalued

Read more

An interview with Thomas Lönngren -- Managing change at the EMA

Read more